The SIX3 Gene Holoprosencephaly Type 2 Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the SIX3 gene, which are known to cause Holoprosencephaly Type 2, a rare congenital disorder. This condition is characterized by the incomplete development of the brain, leading to significant neurological and facial anomalies. The test involves analyzing the patient's DNA to identify any genetic alterations in the SIX3 gene that might be responsible for the disorder.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, this test offers families and individuals crucial information regarding the genetic underpinnings of Holoprosencephaly Type 2. Understanding the genetic basis of the condition can aid in making informed decisions about medical care, potential interventions, and family planning. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the SIX3 gene.
The RAPSN gene fetal akinesia deformation sequence genetic test is a specialized diagnostic procedure aimed at identifying mutations in the RAPSN gene, which are linked to the development of fetal akinesia deformation sequence (FADS). FADS is a rare genetic disorder characterized by reduced fetal movement (akinesia), which can lead to a range of physical deformities and developmental issues in newborns, including joint contractures, facial anomalies, and lung hypoplasia. The RAPSN gene plays a crucial role in the development and function of the neuromuscular junction, and mutations in this gene can disrupt normal muscle movement and growth.
Performed at DNA Labs UAE, this test is an important tool for expecting parents with a family history of neuromuscular disorders or for cases where fetal akinesia or related deformities are suspected during pregnancy. Early and accurate diagnosis through this test can aid in the management of the condition and in making informed decisions regarding the pregnancy.
The cost of the RAPSN gene fetal akinesia deformation sequence genetic test at DNA Labs UAE is 4400 AED. This investment includes the collection of a sample, typically through amniocentesis or chorionic villus sampling, and comprehensive genetic analysis to detect any mutations in the RAPSN gene. Given the complexity and specificity of the test, it represents a critical step towards understanding the genetic underpinnings of FADS and facilitating better outcomes for affected families.
The CRLF1 gene cold-induced sweating syndrome genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the CRLF1 gene responsible for cold-induced sweating syndrome (CISS). CISS is a rare genetic disorder characterized by abnormal sweating and feeding difficulties in response to cold temperatures, among other symptoms. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic alterations in the CRLF1 gene that may lead to the condition. This information is crucial for confirming a diagnosis, understanding the condition's inheritance pattern, and guiding management and treatment strategies for affected individuals and their families. DNA Labs UAE offers this test with state-of-the-art genetic testing technologies, ensuring accurate and reliable results for patients seeking insights into this rare genetic syndrome.
The CLCF1 gene cold-induced sweating syndrome type 2 genetic test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the CLCF1 gene, which are associated with cold-induced sweating syndrome type 2 (CISS2). CISS2 is a rare genetic disorder characterized by an abnormal response to cold temperatures, leading to excessive sweating primarily on the back and chest, as well as other developmental issues including muscle weakness and feeding difficulties. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect any genetic anomalies in the CLCF1 gene, providing crucial information for accurate diagnosis and management of the condition. This test is essential for families with a history of CISS2, offering them the opportunity for early intervention and supportive care to improve quality of life for affected individuals.
The "FOXF2 Gene Disorders of Sex Development with Cleft Palate Genetic Test" is a specialized diagnostic evaluation available at DNA Labs UAE, designed to identify genetic abnormalities associated with disorders of sex development (DSD) and cleft palate that are linked to mutations in the FOXF2 gene. This gene plays a crucial role in embryonic development, including the development of the reproductive system and facial structures. Mutations in the FOXF2 gene can lead to a spectrum of developmental issues, notably affecting sex differentiation and causing cleft palate, a condition characterized by a split in the roof of the mouth.
This test is particularly valuable for individuals presenting with symptoms of DSD and cleft palate, families with a history of these conditions, or healthcare providers seeking a genetic explanation for these developmental anomalies in their patients. By analyzing the DNA for specific mutations in the FOXF2 gene, this test can provide definitive diagnostic information, guide treatment decisions, and offer insight into the risk of recurrence in future pregnancies.
The test is priced at 4400 AED and is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost includes the collection of a DNA sample, usually through a blood draw or cheek swab, the genetic analysis, and a comprehensive report detailing the findings. Patients and healthcare providers can use this information to better understand the condition, explore treatment options, and make informed decisions about care and management.
The CASR Gene Hyperparathyroidism Neonatal Severe Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the CASR gene, which are associated with neonatal severe hyperparathyroidism (NSHPT). NSHPT is a rare, inherited disorder characterized by abnormally high levels of calcium in the blood due to overactivity of the parathyroid glands. This condition can lead to severe complications, including skeletal demineralization and failure to thrive, making early detection and management crucial.
Performed at DNA Labs UAE, this test involves analyzing the patient's DNA to identify any genetic alterations in the CASR gene that may predispose infants to this life-threatening condition. The CASR gene plays a critical role in regulating calcium levels in the body, and mutations in this gene can disrupt this balance, leading to NSHPT.
The cost of the CASR Gene Hyperparathyroidism Neonatal Severe Genetic Test is 4400 AED. Given the complexity and the specialized nature of this test, it represents a vital investment in the health and well-being of affected newborns, allowing for prompt and targeted treatment interventions. This test is an essential tool for parents with a family history of the condition or those whose newborns exhibit symptoms indicative of hyperparathyroidism, ensuring that affected infants receive the necessary care and treatment to mitigate the risks associated with this genetic disorder.
The "MT-ATP8 Gene Cardiomyopathy Infantile Hypertrophic MT-ATP8 Related Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the MT-ATP8 gene, which have been linked to the development of infantile hypertrophic cardiomyopathy. This condition is a severe form of heart disease that manifests early in life, leading to the thickening of the heart's walls and potentially resulting in heart failure or sudden death if not diagnosed and managed promptly. The test is particularly crucial for families with a history of the condition or when the disease is suspected based on clinical symptoms.
Performed at DNA Labs UAE, a leading genetic testing facility, the test involves analyzing the patient's DNA to detect mutations in the MT-ATP8 gene that are responsible for the condition. This gene plays a critical role in the production of ATP synthase, an enzyme vital for energy production within heart muscle cells. Mutations can impair heart function, leading to the symptoms associated with hypertrophic cardiomyopathy.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the genetic mutations associated with this condition. By opting for this test, patients and their families can gain valuable insights into the genetic basis of the disease, enabling targeted treatment strategies and informed decisions about management and care. Early detection through genetic testing like the MT-ATP8 related test is essential for improving outcomes and quality of life for affected infants.
The ABCA12 Gene Ichthyosis Congenital Harlequin Fetus Type Genetic Test is a specialized diagnostic examination performed to detect mutations in the ABCA12 gene, which are responsible for a rare and severe skin disorder known as Harlequin Ichthyosis. This condition is characterized by thickened, hard skin that covers the body in large, diamond-shaped plates, separated by deep cracks. It affects newborns and is considered the most severe form of congenital ichthyosis. The test involves analyzing the DNA to identify any genetic alterations in the ABCA12 gene, which plays a crucial role in lipid transport within the skin.
This critical genetic testing is available at DNA Labs UAE, a leading facility in genetic diagnostics that offers a wide range of genetic testing services. The cost of the ABCA12 Gene Ichthyosis Congenital Harlequin Fetus Type Genetic Test is 4400 AED. The test is essential for confirming the diagnosis of Harlequin Ichthyosis, which can aid in the management and care planning for affected infants. It is also valuable for genetic counseling for families with a history of the condition, helping them understand the risks and implications for future pregnancies.
The ITGA6 gene plays a crucial role in the development and maintenance of the skin and mucous membranes. Mutations in this gene are associated with a rare genetic disorder known as Epidermolysis Bullosa Junctionalis with Pyloric Atresia (EB-PA). This condition is characterized by fragile skin that blisters easily in response to minor injuries or friction, along with a congenital obstruction of the pyloric valve of the stomach, which can lead to severe feeding difficulties and require surgical intervention.
At DNA Labs UAE, a genetic test is available for individuals suspected of having EB-PA, targeting mutations in the ITGA6 gene. This test is vital for confirming the diagnosis, understanding the disease's severity, and guiding treatment and management decisions. The cost of the test is 4400 AED. Conducted in a state-of-the-art facility, the test involves analyzing the patient's DNA to identify mutations in the ITGA6 gene that are indicative of Epidermolysis Bullosa Junctionalis with Pyloric Atresia. Results from this test can provide crucial information for affected families regarding prognosis, potential complications, and the risk of recurrence in future pregnancies.
The "PTPN14 Gene Choanal Atresia and Lymphedema Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, designed to identify genetic mutations associated with Choanal Atresia and Lymphedema. Choanal Atresia is a congenital condition characterized by the blockage of the nasal passage, while Lymphedema refers to swelling in an arm or leg caused by a lymphatic system blockage. Both conditions are believed to have genetic underpinnings, particularly involving mutations in the PTPN14 gene.
This test, priced at 4400 AED, involves the collection of a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed in the laboratory to detect any mutations in the PTPN14 gene that might predispose individuals to these conditions. The results from this test can provide crucial information for diagnosing these conditions, understanding their genetic basis, and guiding treatment and management strategies.
DNA Labs UAE, where this test is conducted, is equipped with state-of-the-art technology and staffed by professionals with expertise in genetic testing and analysis. This ensures the accuracy and reliability of the test results, making it a valuable resource for patients and their families seeking answers about these complex conditions.
